SMAD2 and breast carcinoma: The tumor suppressor miR-190 was found to suppress metastasis formation in breast cancer, by directly targeting SMAD2 and antagonizing TGFβ-induced EMT, creating a feedback-loop with TFGβ/SMAD2 signaling in controlling breast cancer EMT and metastasis [79].